Chin-Kai Tseng

944 total citations
34 papers, 715 citations indexed

About

Chin-Kai Tseng is a scholar working on Hepatology, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Chin-Kai Tseng has authored 34 papers receiving a total of 715 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 10 papers in Public Health, Environmental and Occupational Health and 9 papers in Epidemiology. Recurrent topics in Chin-Kai Tseng's work include Hepatitis C virus research (13 papers), Mosquito-borne diseases and control (10 papers) and Viral Infections and Vectors (5 papers). Chin-Kai Tseng is often cited by papers focused on Hepatitis C virus research (13 papers), Mosquito-borne diseases and control (10 papers) and Viral Infections and Vectors (5 papers). Chin-Kai Tseng collaborates with scholars based in Taiwan, United States and Italy. Chin-Kai Tseng's co-authors include Jin‐Ching Lee, Chun‐Kuang Lin, Wei‐Chun Chen, Yu‐Hsuan Wu, Yen‐Hsu Chen, Huey‐Nan Wu, Kuan‐Jen Chen, Fang‐Rong Chang, Ying‐Ting Lin and Hui‐Chun Wang and has published in prestigious journals such as PLoS ONE, Analytical Biochemistry and Scientific Reports.

In The Last Decade

Chin-Kai Tseng

34 papers receiving 702 citations

Peers

Chin-Kai Tseng
Chie Aoki Japan
Omar Janneh United Kingdom
Jessica Wagoner United States
Chin-Kai Tseng
Citations per year, relative to Chin-Kai Tseng Chin-Kai Tseng (= 1×) peers Chun‐Kuang Lin

Countries citing papers authored by Chin-Kai Tseng

Since Specialization
Citations

This map shows the geographic impact of Chin-Kai Tseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chin-Kai Tseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chin-Kai Tseng more than expected).

Fields of papers citing papers by Chin-Kai Tseng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chin-Kai Tseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chin-Kai Tseng. The network helps show where Chin-Kai Tseng may publish in the future.

Co-authorship network of co-authors of Chin-Kai Tseng

This figure shows the co-authorship network connecting the top 25 collaborators of Chin-Kai Tseng. A scholar is included among the top collaborators of Chin-Kai Tseng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chin-Kai Tseng. Chin-Kai Tseng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Tsung‐Ju, Ting‐Wei Lin, Tingyu Lu, et al.. (2023). Phellinus linteus mycelia extract in COVID-19 prevention and identification of its key metabolic compounds profiling using UPLC-QTOF-MS/MS spectrometry. Fitoterapia. 171. 105695–105695. 3 indexed citations
2.
Chang, Po-Chun, Yen‐Chung Lai, Yung‐Chun Chuang, et al.. (2022). Therapeutic efficacy of humanized monoclonal antibodies targeting dengue virus nonstructural protein 1 in the mouse model. PLoS Pathogens. 18(4). e1010469–e1010469. 16 indexed citations
3.
Lin, Chun‐Kuang, Chin-Kai Tseng, Chih‐Chuang Liaw, et al.. (2018). Lobohedleolide suppresses hepatitis C virus replication via JNK/c-Jun-C/EBP-mediated down-regulation of cyclooxygenase-2 expression. Scientific Reports. 8(1). 8676–8676. 6 indexed citations
4.
Lee, Jin‐Ching, et al.. (2017). Discovery of novel diarylpyrazolylquinoline derivatives as potent anti-dengue virus agents. European Journal of Medicinal Chemistry. 141. 282–292. 12 indexed citations
5.
Tseng, Chih-Hua, et al.. (2017). Discovery of naphtho[1,2-d]oxazole derivatives as potential anti-HCV agents through inducing heme oxygenase-1 expression. European Journal of Medicinal Chemistry. 143. 970–982. 17 indexed citations
6.
Chen, Wei‐Chun, et al.. (2016). Sulforaphane Suppresses Hepatitis C Virus Replication by Up-Regulating Heme Oxygenase-1 Expression through PI3K/Nrf2 Pathway. PLoS ONE. 11(3). e0152236–e0152236. 44 indexed citations
7.
Chen, Wei‐Chun, Chin-Kai Tseng, Bing‐Hung Chen, Chun‐Kuang Lin, & Jin‐Ching Lee. (2016). Grape Seed Extract Attenuates Hepatitis C Virus Replication and Virus-Induced Inflammation. Frontiers in Pharmacology. 7. 490–490. 17 indexed citations
8.
Chen, Wei‐Chun, Chin-Kai Tseng, Yen‐Hsu Chen, et al.. (2015). HCV NS5A Up-Regulates COX-2 Expression via IL-8-Mediated Activation of the ERK/JNK MAPK Pathway. PLoS ONE. 10(7). e0133264–e0133264. 29 indexed citations
9.
Lee, Jin‐Ching, Chin-Kai Tseng, Yu‐Hsuan Wu, et al.. (2015). Characterization of the activity of 2′-C-methylcytidine against dengue virus replication. Antiviral Research. 116. 1–9. 62 indexed citations
11.
Tseng, Chih-Hua, Chun‐Kuang Lin, Yeh‐Long Chen, et al.. (2014). Synthesis, antiproliferative and anti-dengue virus evaluations of 2-aroyl-3-arylquinoline derivatives. European Journal of Medicinal Chemistry. 79. 66–76. 28 indexed citations
12.
Chen, Wei‐Chun, et al.. (2013). Anti-hepatitis C virus RdRp activity and replication of novel anilinobenzothiazole derivatives. Antiviral Research. 100(1). 269–275. 5 indexed citations
13.
Lin, Ying‐Ting, Yu‐Hsuan Wu, Chin-Kai Tseng, et al.. (2013). Green Tea Phenolic Epicatechins Inhibit Hepatitis C Virus Replication via Cycloxygenase-2 and Attenuate Virus-Induced Inflammation. PLoS ONE. 8(1). e54466–e54466. 61 indexed citations
14.
Chen, Kuan‐Jen, Chin-Kai Tseng, Fang‐Rong Chang, et al.. (2013). Aqueous Extract of the Edible Gracilaria tenuistipitata Inhibits Hepatitis C Viral Replication via Cyclooxygenase-2 Suppression and Reduces Virus-Induced Inflammation. PLoS ONE. 8(2). e57704–e57704. 35 indexed citations
15.
Lin, Ying‐Ting, et al.. (2011). Efficient In Silico Assay of Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase by Structure-Based Virtual Screening and In Vitro Evaluation. Assay and Drug Development Technologies. 9(3). 290–298. 8 indexed citations
16.
Tseng, Chin-Kai, Kuan‐Jen Chen, Chun‐Kuang Lin, Shih‐Hsien Hsu, & Jin‐Ching Lee. (2011). An in vitro coupled transcription/translation reporter system for hepatitis C virus RNA-dependent RNA polymerase. Analytical Biochemistry. 418(1). 50–57. 5 indexed citations
17.
Lin, Chun‐Kuang, et al.. (2011). Synthesis and anti-HCV activity evaluation of anilinoquinoline derivatives. Bioorganic & Medicinal Chemistry Letters. 22(2). 1107–1110. 16 indexed citations
18.
Lee, Jin‐Ching, et al.. (2010). A cell-based reporter assay for inhibitor screening of hepatitis C virus RNA-dependent RNA polymerase. Analytical Biochemistry. 403(1-2). 52–62. 39 indexed citations
19.
Lai, Chung‐Sheng, et al.. (1996). Continuous Thoracic Epidural Anesthesia for Breast Augmentation. Annals of Plastic Surgery. 36(2). 113–116. 11 indexed citations
20.
Tang, Chao-Shun, et al.. (1993). Retrospective investigation of intermittent bolus intrathecal morphine for cancer pain patients.. PubMed. 9(11). 632–42. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026